Leap Therapeutics (LPTX) Misses Q2 EPS by 40c
Tweet
Share
E-mailGet Alerts LPTX Hot Sheet
Join SI Premium – FREE
Leap Therapeutics (NASDAQ: LPTX) reported Q2 EPS of ($0.40), $0.40 worse than the analyst estimate of $0.00.
For earnings history and earnings-related data on Leap Therapeutics (LPTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wolfe Research Upgrades PulteGroup (PHM) to Outperform
- DocMorris AG (DOCM:SW) PT Raised to CHF12.50 at Deutsche Bank
- Humana (HUM) PT Raised to $450 at Wolfe Research
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
